These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33497941)

  • 41. [Disease transformation in imatinib mesylate treated Philadelphia chromosome-positive chronic myelogenous leukemia patients achieved cytogenetic remissions].
    Jiang Q; Chen SS; Jiang B; Jiang H; Lu Y; Lu DP
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 37(6):612-5. PubMed ID: 16378113
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of imatinib mesylate on patients with Philadelphia chromosome-positive chronic myeloid leukemia with secondary chromosomal aberrations.
    Mohamed AN; Pemberton P; Zonder J; Schiffer CA
    Clin Cancer Res; 2003 Apr; 9(4):1333-7. PubMed ID: 12684401
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterisation of clonal Philadelphia-negative cytogenetic abnormalities in a large cohort of chronic myeloid leukaemia.
    Chen X; Zheng J; Liang K; He Y; Du W; Li J; Liu W; Hu Y; Huang S; Yao J
    Intern Med J; 2018 Apr; 48(4):439-444. PubMed ID: 28636094
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potential role for second‑generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia harboring additional clonal chromosome abnormalities: A retrospective CML Cooperative Study Group analysis.
    Ishikawa M; Iriyama N; Tokuhira M; Takaku T; Sato E; Sugimoto KJ; Nakazato T; Fujita H; Kimura Y; Fujioka I; Komatsu N; Asou N; Kizaki M; Hatta Y; Kawaguchi T
    Oncol Rep; 2019 Dec; 42(6):2836-2843. PubMed ID: 31578586
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Additional chromosomal abnormalities at chronic myeloid leukemia diagnosis predict an increased risk of progression.
    Clark RE; Apperley JF; Copland M; Cicconi S
    Blood Adv; 2021 Feb; 5(4):1102-1109. PubMed ID: 33616651
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Double minute chromosomes and monosomy 7 in a lymphatic blast crisis of chronic myeloid leukemia.
    Cigudosa JC; Calasanz MJ; Gullon A; Ezpeleta I; Oyarzabal FJ
    Cancer Genet Cytogenet; 1990 Aug; 48(1):133-4. PubMed ID: 2372781
    [No Abstract]   [Full Text] [Related]  

  • 47. Complete cytogenetic and molecular response after imatinib treatment for chronic myeloid leukemia in a patient with atypical karyotype and BCR-ABL b2a3 transcript.
    Pienkowska-Grela B; Woroniecka R; Solarska I; Kos K; Pastwińska A; Konopka L; Majewski M
    Cancer Genet Cytogenet; 2007 Apr; 174(2):111-5. PubMed ID: 17452251
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL+ leukemias: incidence and underlying genetic abnormalities.
    Primo D; Tabernero MD; Rasillo A; Sayagués JM; Espinosa AB; Chillón MC; Garcia-Sanz R; Gutierrez N; Giralt M; Hagemeijer A; San Miguel JF; Orfao A
    Leukemia; 2003 Jun; 17(6):1124-9. PubMed ID: 12764379
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib mesylate.
    O'Dwyer ME; Gatter KM; Loriaux M; Druker BJ; Olson SB; Magenis RE; Lawce H; Mauro MJ; Maziarz RT; Braziel RM
    Leukemia; 2003 Mar; 17(3):481-7. PubMed ID: 12646934
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Deletion (7)(p11p15): an infrequent abnormality in blast crisis in chronic myeloid leukemia].
    Resino M; Ferro MT; García-Laraña J; García-Sagredo JM; Cabello P; López-Yarto A; San Román C
    Sangre (Barc); 1994 Dec; 39(6):465-7. PubMed ID: 7855700
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Analysis of cytogenetic response in Ph+ chronic myeloid leukemia patients treated with interferon alpha].
    Hong H; Qiu JY; Lai YY; Shi Y; He Q; Dang H; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Jun; 11(3):269-73. PubMed ID: 12844411
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Presence of Additional Cytogenetic Abnormality of t(1;15) at Diagnosis of Chronic Myelogenous Leukemia-Chronic Phase.
    Ji M; Hur M; Kim HN; Moon HW; Yun YM; Kim SY; Han SH
    Ann Clin Lab Sci; 2016 May; 46(3):308-11. PubMed ID: 27312558
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Double minutes containing amplified bcr-abl fusion gene in a case of chronic myeloid leukemia treated by imatinib.
    Morel F; Bris MJ; Herry A; Calvez GL; Marion V; Abgrall JF; Berthou C; Braekeleer MD
    Eur J Haematol; 2003 Apr; 70(4):235-9. PubMed ID: 12656747
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Extensive cytogenetic studies of clonality following interferon-alpha therapy in chronic myeloid leukemia occurring in monosomic cells in a patient with Turner syndrome mosaic.
    Takeshita A; Shinjo K; Yamashita M; Fujisawa S; Naito K; Ohnishi K; Takahashi K; Matsui H; Ohno R
    Leukemia; 1999 Nov; 13(11):1749-53. PubMed ID: 10557048
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Additional chromosome abnormalities, BCR-ABL tyrosine kinase domain mutations and clinical outcome in Hungarian tyrosine kinase inhibitor-resistant chronic myelogenous leukemia patients.
    Meggyesi N; Kozma A; Halm G; Nahajevszky S; Bátai A; Fekete S; Barta A; Ujj G; Lueff S; Sipos A; Adám E; Bors A; Reményi P; Masszi T; Tordai A; Andrikovics H
    Acta Haematol; 2012; 127(1):34-42. PubMed ID: 22005133
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic Mutations in a Patient with Chronic Myeloid Leukemia Showing Blast Crisis 10 Years After Presentation.
    Sklarz LM; Wittke C; Krohn S; GROßE-Thie C; Junghanss C; Murua Escobar H; Glaeser H
    Anticancer Res; 2018 Jul; 38(7):3961-3966. PubMed ID: 29970518
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Chromosomal abnormalities in 38 CML cases of various phases].
    Su XY; Cao Q; He KL
    Zhonghua Yi Xue Za Zhi; 1999 Jan; 79(1):34-7. PubMed ID: 11601004
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reconsideration of BCR-ABL protein flow cytometric immunobead assay: how potent to diagnose and monitor chronic myeloid leukemia?
    Kelani R; Monem F
    Int J Lab Hematol; 2015 Oct; 37(5):723-8. PubMed ID: 26059167
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clonal chromosome aberrations in Philadelphia-negative cells from chronic myelocytic leukemia patients treated with imatinib mesylate: report of two cases.
    Herens C; Baron F; Croisiau C; Tassin F; Bours V
    Cancer Genet Cytogenet; 2003 Nov; 147(1):78-80. PubMed ID: 14580776
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transient trisomy 8 abnormality in Philadelphia-negative cells during imatinib mesylate treatment of chronic myelogenous leukemia.
    Kim M; Lee S; Jung CK; Lim J; Cho SG; Kim DW; Kim Y; Han K; Min WS; Kim CC
    Int J Lab Hematol; 2008 Dec; 30(6):508-12. PubMed ID: 18983302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.